Susquehanna International Group, LLP Halozyme Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$37.81 - $52.4 $18,905 - $26,200	-500 Reduced 1.07%	46,200 $2.42 Million
Q1 2024 May 07, 2024	SELL	$33.68 - $41.95 $63,992 - $79,705	-1,900 Reduced 3.91%	46,700 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $483,140 - $610,450	14,500 Added 42.52%	48,600 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $2.17 Million - $2.62 Million	-59,500 Reduced 63.57%	34,100 $1.3 Million
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $1.38 Million - $1.77 Million	45,600 Added 95.0%	93,600 $3.38 Million
Q1 2023 May 16, 2023	BUY	$32.86 - $55.7 $420,608 - $712,960	12,800 Added 36.36%	48,000 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $372,558 - $552,792	-9,300 Reduced 20.9%	35,200 $2 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $169,532 - $227,832	4,400 Added 10.97%	44,500 $1.76 Million

488

122M

208K

66.3K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.89B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.